TITLE

Embryonic Stem Cell Research Moves Slowly Through Appeals Courts, Cancer Trials

AUTHOR(S)
Jenks, Susan
PUB. DATE
July 2011
SOURCE
JNCI: Journal of the National Cancer Institute;Jul2011, Vol. 103 Issue 14, p1078
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the status of embryonic stem cell research in the U.S., noting the slow progress due to legal disputes which are affecting funding support. It cites the court case between the National Institutes of Health (NIH) and the two scientists James Sherley and Theresa Deisher on the issue of adult stem cells versus embryonic stem cells with regard to federal funding. Also mentioned are privately-funded trials involving embryonic stem cells in the treatment of some diseases, and some research on cancer treatment using these early cells.
ACCESSION #
62989496

 

Related Articles

  • Court Says Yes to Stem Cell Funding, Boosts Free Speech. Serebrov, Mari // BioWorld Today;8/27/2012, Vol. 23 Issue 166, p1 

    The article reports on the decision of the U.S. Court of Appeals for the District of Columbia Circuit to uphold the National Institutes of Health's (NIH) 2009 guidelines permitting funding of human embryonic stem cell research. In Sherley v. Sebelius, researchers James Sherley and Theresa...

  • Court upholds funding of embryonic stem cell research. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;10/2/2012, Vol. 184 Issue 14, pE749 

    The article presents information on a ruling of the U.S. Appellate Court related to funding of embryonic stem cell research. It informs that the court has rejected the appeal made by two stem cell researchers including James Sherley and Theresa Deisher who wanted to stop federal funding on stem...

  • ]OF SCIENCE AND SNOWFLAKES: CONGRESSIONAL INTENT AND THE CASE AGAINST SHERLEY V. SEBELIUS. Allison, Wes // Charleston Law Review;Summer2011, Vol. 5 Issue 4, p521 

    The article discusses the U.S. Congressional intent and the court case Sherley v. Sebelius. It notes the ruling of the District Court in Washington, D.C. that the Congress prohibits human embryonic stem cell (ESC) research funding and that the National Institutes of Health (NIH) is not equipped...

  • NIH Approves ACT Stem Cell Line.  // BioWorld Today;6/14/2010, Vol. 21 Issue 113, p2 

    The article announces the approval by the National Institutes of Health (NIH) of federal funding for the MA135 human embryonic stem cell (hESC) line from Advanced Cell Technology Inc.

  • ...and ES cell strategy. Ready, Tinker // Nature Medicine;May2001, Vol. 7 Issue 5, p518 

    Reports on the plan of the U.S. regarding research into embryonic stem cells (ES). Inability of the U.S. government to approve the legislation banning human cloning; Response of scientists to the guidelines prepared by National Institutes of Health; Establishment of a coalition for the support...

  • Stem Cell Transplants.  // NSTA Reports!;Nov2007, Vol. 19 Issue 3, p6 

    The article focuses on the issues involving embryonic stem cell and transplantation. The U.S. National Institutes of Health provides the information that stem cells may treat several diseases including Parkinson's disease. However, anti-abortionists question the application of stem cells in the...

  • Stem cell research funding in jeopardy.  // Issues in Science & Technology;Winter2010, Vol. 27 Issue 2, p24 

    The article reports on the preliminary injunction issued by a federal judge that forbids the National Institutes of Health (NIH) to fund stem cell research in the U.S. District Court Judge Royce C. Lamberth said that under the Dickey-Wicker Amendment, human embryonic stem cell research is...

  • Temporary reprieve for stem cells. Wadman, Meredith // Nature;9/16/2010, Vol. 467 Issue 7313, p258 

    The article reports on the challenges faced by scientists after the temporary reversal of a court injunction that shut down government funding for human embryonic stem-cell research in the U.S. National Institutes of Health (NIH) director Francis Collins states that they pleased with the interim...

  • Tracking and assessing the rise of state-funded stem cell research. Karmali, Ruchir N.; Jones, Natalie M.; Levine, Aaron D. // Nature Biotechnology;Dec2010, Vol. 28 Issue 12, p1246 

    A letter to the editor is presented in response to the editorial in the October 2010 issue which highlights the legal challenges to the new guidelines issued by the U.S. National Institutes of Health (NIH) in July 2009 for the federal funding of human embryonic stem cell (hESC) research.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics